A recent study [55] has shown that TNTs contribute to the progression of colorectal cancer by upregulating ERK (extracellular signal regulated kinase) expression in recipient cells by transferring mutant KRAS to these cells. The gene discussed is KRAS; the disease is colorectal cancer.